Citation Impact
Citing Papers
Microbial Cellulose Utilization: Fundamentals and Biotechnology
2002 Standout
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance
2002
A Predominantly Clonal Multi-Institutional Outbreak ofClostridium difficile–Associated Diarrhea with High Morbidity and Mortality
2005 Standout
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
2012 Standout
Opportunistic Mycoses in the Immunocompromised Host: Experience at a Cancer Center and Review
1992
Nosocomial Candidiasis: Emerging Species, Reservoirs, and Modes of Transmission
1996
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole
1991 Standout
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
2003
The Bacteroides fragilis cell envelope: Quarterback, linebacker, coach—or all three?
2006
CLINICAL RELEVANCE OF ANTIFUNGAL RESISTANCE
1997
Upconverting Nanoparticles
2011 Standout
Current role of LC-MS in therapeutic drug monitoring
2007
Properties and applications of calcium hydroxide in endodontics and dental traumatology
2011 Standout
Resistance to amphotericin B: emerging clinical and microbiological patterns
1998
Nosocomial infections in a Brazilian Burn Unit
2006
Molecular typing of actinomyces pyogenes isolates
1994
Detection and quantification of Panton–Valentine leukocidin in Staphylococcus aureus cultures by ELISA and Western blotting: Diethylpyrocarbonate inhibits binding of protein A to IgG
2010
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance
1996
Voriconazole, a novel wide‐spectrum triazole: oral pharmacokinetics and safety
2003
The threat of antimicrobial resistance in developing countries: causes and control strategies
2017 Standout
Candida lusitaniae: A Cause of Breakthrough Fungemia in Cancer Patients
2001
Influence of multidrug efflux systems on methylene blue-mediated photodynamic inactivation of Candida albicans
2011
PI3K signaling of autophagy is required for starvation tolerance and virulenceof Cryptococcus neoformans
2008 StandoutNobel
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
2010 Standout
Human cysteine-proteinase inhibitors: nucleotide sequence analysis of three members of the cystatin gene family
1987 StandoutNobel
Trends in the postmortem epidemiology of invasive fungal infections at a University Hospital
1996 Standout
Echinocandin antifungal drugs
2003 Standout
Spoilage yeasts in the wine industry
2003
High rate of non-albicans candidemia in Brazilian tertiary care hospitals
1999 Standout
Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections
1997
The chemistry and biological significance of saponins in foods and feedingstuffs
1987 Standout
Synthesis and antimicrobial activity of some new hydrazones of 4-fluorobenzoic acid hydrazide and 3-acetyl-2,5-disubstituted-1,3,4-oxadiazolines
2002
Influence of diet on the gut microbiome and implications for human health
2017 Standout
Candidiasis
1989
The avidin-biotin complex in bioanalytical applications
1988
Sialic Acid as Receptor of Bacteroides fragilis Lectin-like Adhesin
1992
Cyclodextrin-based pharmaceutics: past, present and future
2004 Standout
Antifungal Susceptibility Testing: Technical Advances and Potential Clinical Applications
1997
Two Cases of Fungemia due to Candida lusitaniae and a Literature Review
2002
Importance of Candida Species Other than C. albicans as Pathogens in Oncology Patients
1995
Emergence of Resistance to Amphotericin B During Therapy for Candida glabrata Infection in an Immunocompetent Host
1996
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring
2014 StandoutNobel
A review of nucleic acid-based diagnostic tests for systemic mycoses with an emphasis on polymerase chain reaction-based assays
2002
Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis
2010 Standout
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
2002 Standout
Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniae
1994
Fluconazole
1995
Antifungal drug resistance
1995
Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14 alpha-demethylase and aromatase.
2002 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Candida Infections of Medical Devices
2004 Standout
Risk Factors for Clostridium difficile Carriage and C. difficile-Associated Diarrhea in a Cohort of Hospitalized Patients
1990
The different electrophoretic forms of post γ-globulin their antigenic identity and their structural variability
1977
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Improved Detection of Amphotericin B-Resistant Isolates of Candida lusitaniae by Etest
2001
Partial amino acid sequences of human and dog post-gamma globulins
1981 StandoutNobel
Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program
2004
Synthesis, characterization and antimicrobial evaluation of ethyl 2-arylhydrazono-3-oxobutyrates
1999
On-Line Monitoring and Identification of Bioaerosols
2006
Biological Activities of Hydrazone Derivatives
2007 Standout
Laboratory diagnosis of invasive candidiasis.
2005
Antifungal susceptibility testing
1993
Not your ordinary yeast: non-Saccharomycesyeasts in wine production uncovered
2013 Standout
Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance
1999 Standout
Current and Emerging Azole Antifungal Agents
1999 Standout
Clinical aspects related to endodontic yeast infections
2004
Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts
1993
Candida: A Causative Agent of an Emerging Infection
2001
2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa
2015 Standout
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
1998
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance
1984
Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality
2005 Standout
Antimicrobial photodynamic therapy – what we know and what we don’t
2018 Standout
Development of an Immunochromatographic Strip for Simple Detection of Penicillin-Binding Protein 2′
2010 StandoutNobel
Patterns of Amphotericin B Killing Kinetics against Seven Candida Species
2004
Aspergillus fumigatusand Aspergillosis
1999 Standout
High-Frequency, In Vitro Reversible Switching of Candida lusitaniae Clinical Isolates from Amphotericin B Susceptibility to Resistance
1999
Treatment of Severe Candida Infections in High-Risk Patients in Germany: Consensus Formed by a Panel of Interdisciplinary Investigators
2002
Correlation of Fluconazole MICs with Clinical Outcome in Cryptococcal Infection
2000
Clinical microbiology of coryneform bacteria
1997 Standout
Change in Colony Morphology of Candida lusitaniae in Association with Development of Amphotericin B Resistance
2002
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis.
1982
Detection of Streptococcus pneumoniae Antigen by a Rapid Immunochromatographic Assay in Urine Samples
2001
Electrogenerated Chemiluminescence and Its Biorelated Applications
2008 Standout
Activity of compound G2 isolated from alfalfa roots against medically important yeasts
1986
Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates
1995
Socioeconomic and Behavioral Factors Leading to Acquired Bacterial Resistance to Antibiotics in Developing Countries
1999
Partial amino acid sequence of two forms of human Post-γ-globulin
1979
Fatal Disseminated Candidiasis Due to Amphotericin-B-Resistant Candida guilliermondii
1985
Isolation and characterization of Clostridium hobsonii comb. nov.
1995
Guidelines for Treatment of Candidiasis
2004 Standout
Antifungal Susceptibility Testing: Practical Aspects and Current Challenges
2001
Primary biological aerosol particles in the atmosphere: a review
2012 Standout
Bacteroides: the Good, the Bad, and the Nitty-Gritty
2007 Standout
Disruption of Ergosterol Biosynthesis Confers Resistance to Amphotericin B inCandida lusitaniae
2003
Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard
1994
Hidden Killers: Human Fungal Infections
2012 Standout
Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome
1996
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
1995 Standout
Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America
2007 Standout
Drug Resistance in Leishmaniasis
2006 Standout
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Works of R Guinet being referenced
Evaluation of five commercial antifungal susceptibility testing systems
1993
Yeast identification in the clinical microbiology laboratory: phenotypical methods
2001
Protein A insensitive ELISA detection of staphylococcal enterotoxin B
1991
Highly sensitive biotin-avidin sandwich ELISA for the rapid detection of pneumococcal capsular polysaccharide antigens
1987
Evaluation of six commercial systems for identification of medically important yeasts
1998
Evaluation of latex reagents for rapid identification of Candida albicans and C. krusei colonies
1997
Survey of primary drug resistance of Mycobacterium tuberculosis in Casablanca, Morocco.
1997
Clostridium difficile and its cytotoxin in diarrhoeic stools of hospitalized patients. Toxigenic potential of the isolates.
1989
Reproducible measurement of amphotericin B in serum by high-performance liquid chromatography in alkaline buffer
1985
Occurrence of β2-microglobulin and post-γ globulin in human semen
1976
Lectinlike adhesins in the Bacteroides fragilis group
1986
Fatal septicemia due to amphotericin B-resistant Candida lusitaniae
1983
A rapid and sensitive non-competitive avidin-biotin immuno-enzymatic assay for lysozyme
1986
[Sensitivity of Aspergillus to ketoconazole and itraconazole using a standardized micromethod].
1990
Improved SDS-Page method for protein profiles analysis of actinomyces species.
1988
[Comparative sensitivity of yeasts to ketoconazole, itraconazole and fluconazole using a liquid medium standardized micromethod].
1990
Collaborative evaluation in seven laboratories of a standardized micromethod for yeast susceptibility testing
1988